NCM
DGX icon

Northwest Capital Management’s Quest Diagnostics DGX Stock Holding History

Northwest Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-52
Closed -$8.8K – 377
2025
Q1 		$8.8K Hold
52
– – ﹤0.01% 325
2024
Q4 		$7.84K Hold
52
– – ﹤0.01% 329
2024
Q3 		$8.07K Hold
52
– – ﹤0.01% 338
2024
Q2 		$7.12K Hold
52
– – ﹤0.01% 338
2024
Q1 		$6.92K Hold
52
– – ﹤0.01% 418
2023
Q4 		$7.17K Hold
52
– – ﹤0.01% 404
2023
Q3 		$6.34K Hold
52
– – ﹤0.01% 401
2023
Q2 		$7.31K Buy
+52
New +$7.17K ﹤0.01% 405

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northwest Capital Management's DGX Position: Q2 2025 in Review

Northwest Capital Management sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 52 shares — an estimated $8.8K sold.

Northwest Capital Management first reported a position in DGX in Q2 2023 and held it in 8 quarters. The position peaked at $8.8K in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Northwest Capital Management reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Northwest Capital Management sold 52 Quest Diagnostics shares in Q2 2025, an estimated $8.8K.
  • Northwest Capital Management first reported a position in Quest Diagnostics in Q2 2023 and held it in 8 quarters.
  • Northwest Capital Management's Quest Diagnostics position peaked at $8.8K in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Northwest Capital Management's 13F filing for Q2 2025, filed 25 Jul 2025.